On of the reasons I would like to see the TNBC’s first injection announced. There is a possibility, the market reacts positively this time with the excitement on the ctc number indications shortly following ... which could be HUGE for this stock. I’m probably overly positive here because this ccr5 connection now has been documented in many types of cancers with many researchers, not just a fluke study, and also confirmed in human trials, though with maraviroc, but still very positive indications so far. With maraviroc’s success, one would think the cancer-ccr5 patents themselves would be adding value now.

Next week would be a great time to PR the first injection. Also maybe the mono pivotal trial submission, but if they do pr the injection next week, they should save the mono trial PR for the following week.